Quantitative changes of a CD8+CD28− (CD8+CD57+) lymphocytes population have been observed in autoimmune diseases such as multiple sclerosis [23], type 1 diabetes [23], Graves' disease [24], and rheumatoid arthritis [25]. This evidence concerns the gene CD8A and rheumatoid arthritis.